TD Asset Management Inc lowered its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 11.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 197,641 shares of the health services provider’s stock after selling 24,520 shares during the period. TD Asset Management Inc’s holdings in Cigna Group were worth $54,397,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Beacon Financial Strategies CORP acquired a new stake in shares of Cigna Group in the 4th quarter valued at $28,000. Collier Financial acquired a new stake in shares of Cigna Group in the 3rd quarter valued at $34,000. Lodestone Wealth Management LLC bought a new position in shares of Cigna Group in the fourth quarter valued at about $32,000. Creative Financial Designs Inc. ADV raised its holdings in shares of Cigna Group by 147.3% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after buying an additional 81 shares during the last quarter. Finally, Activest Wealth Management raised its holdings in shares of Cigna Group by 1,050.0% in the fourth quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after buying an additional 126 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on CI shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Monday. Morgan Stanley lifted their price target on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Jefferies Financial Group dropped their price objective on Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a report on Monday, April 20th. Sanford C. Bernstein boosted their price objective on Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a report on Tuesday, May 5th. Finally, Raymond James Financial set a $340.00 price objective on Cigna Group in a report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $338.30.
Insider Activity
In other news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.
Cigna Group Price Performance
Cigna Group stock opened at $290.17 on Friday. The firm has a market capitalization of $76.76 billion, a P/E ratio of 12.30, a PEG ratio of 1.08 and a beta of 0.28. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89. The business has a 50-day moving average of $279.58 and a 200-day moving average of $277.24. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69.
Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the company earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, equities analysts anticipate that Cigna Group will post 30.39 EPS for the current year.
Cigna Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is presently 26.45%.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Recommended Stories
- Five stocks we like better than Cigna Group
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
